[Treatment of acute respiratory tract diseases in cattle with Bisolvon in combination with either enrofloxacin, cefquinome, ceftiofur or florfenicol]. / Untersuchungen zur Behandlung von akuten Atemwegserkrankungen bei Rindern mit Bisolvon in Kombination mit entweder Enrofloxacin, Cefquinom, Ceftiofur oder Florfenicol.

The purpose of the present clinical studies was to determine the clinical efficacy of a combined parenteral and oral treatment with Bisolvon in combination with antibiotics in bovines suffering from acute respiratory disease. To this end four trials were conducted in respiratory diseased bovines; a total of 619 animals were evaluated. The animals were randomly assigned to one of two treatment groups within each study and were treated either with enrofloxacin, cefquinome, ceftiofur or florfenicol. The Bisolvon group was additionally treated with Bisolvon over 5 consecutive days. Daily clinical examinations were carried out over a period of 6 days. The clinical respiratory score, the primary parameter, representing a summation of the scoring points for the parameters respiratory rate, nasal discharge, spontaneous coughing, lung sounds and grade of dyspnoea and the clinical index score, which additionally included the general parameters fever, demeanour and feed intake, were significantly lower in the Bisolvon groups compared to the controls at all examinations after initiation of therapy in all trials with the exception of day 2 in one study. Lower values correspond to a less severe clinical condition. This consistent result as well as the evaluation of the single parameters are indicative of an acceleration of the recovery of the animals additionally treated with Bisolvon.

Dose-response relationship for the antipyretic effect of meloxicam in an endotoxin model in cats.

The antipyretic efficacy of meloxicam was evaluated in a feline endotoxin model using a replicated change-over design. Twelve adult cats of both sexes were allocated at random to three experimental groups. At 30 min prior to the intravenous (i.v.) endotoxin challenge (0.5 microgram/kg body weight(b.w.)), 2 animals in each group received an i.v. injection of 0.1, 0.3 or 0.5 mg meloxicam/kg b.w. and the two remaining animals in each group received physiological saline. In a second phase, 21 days later, the meloxicam/placebo treatment was exchanged within each group. The rectal temperature and scores for general demeanour were determined at 30-min intervals from before dosing to 300 min after the endotoxin challenge. Haematological parameters were analysed before and 60 min after administration of endotoxin. The results indicated a significant dose-dependent antipyretic response to meloxicam after endotoxin challenge. The antipyretic response in the medium- and high-dose meloxicam groups did not differ significantly, but both were significantly different from the low-dosage group. The individual effects of endotoxin on general demeanour were rather variable but meloxicam tended to have a beneficial effect. Endotoxin induced a reduction in the white blood cell count but this was not influenced by meloxicam. It was concluded that the pyretic endotoxin model is very suitable for studying new NSAIDs in cats and that the optimum single dose of meloxicam in this model was 0.3 mg/kg b.w.

The effect of acute and chronic administration of the beta-agonist, cimaterol, on protein synthesis in ovine skin and muscle.

The action of intravenous infusion of the beta-agonist cimaterol (2.5 mg/d) on whole-body N retention and protein synthesis in peripheral tissues was examined in growing sheep. Wool growth was determined from skin patch clippings and adjusted to total fibre production. Protein synthesis was measured, using sequential large dose injections of [1-13C]valine, leucine and phenylalanine and then [ring-d5]phenylalanine, on biopsy samples from skin and m. longissimus dorsi taken before beta-agonist administration, at day 3 and day 15 of cimaterol infusion, and 15 d after withdrawal of the drug. Cimaterol increased total N retention by 1.9-2.3 g N/d (P < 0.01) over three successive 5 d periods. In contrast, wool growth was significantly reduced by 0.7 g N/d (P < 0.001) and the proportion of total N retained in wool declined from 0.71 to 0.25 (P < 0.01). The reduction in wool growth was accompanied by a decrease in protein fractional synthesis rate (FSR) in skin (11.6 v. 6.3%/d, P < 0.01). Muscle protein FSR, on the other hand, was markedly stimulated during cimaterol infusion (1.45 v. 3.01%/d, P < 0.001) as was RNA concentration (P < 0.001), RNA:protein (P < 0.001) and protein:DNA (P < 0.05). The estimated increase in total protein synthesis in muscle (+24 to 30 g/d) due to cimaterol administration was counterbalanced by reductions for skin (-25 to 27 g/d); this may account for the lack of changes in whole-body protein synthesis following beta-agonist administration reported in other studies. Although N retention rapidly returned to control values following withdrawal of the drug, both wool growth and skin protein synthesis remained depressed, while muscle protein FSR declined, but not to pre-treatment values. These results suggest a persistent action of cimaterol, but whether this is a function of residue concentrations or long-term metabolic responses is not known.

Preliminary observations on the effects of meloxicam in a new model for acute intra-articular inflammation in dogs.

The effects of intra-articular injection, on two occasions, 3 weeks apart, of the contrast agent Urografin on the cytological and biochemical characteristics of synovial fluid (SF) were examined in two studies in dogs. The first study provided baseline data in two non-medicated dogs. The second study used a cross-over design whereby 4 dogs received a 7-day oral treatment with either a placebo or meloxicam (0.2 mg/kg body weight daily) with a washout period of 3 weeks, in order to determine the effect of this new non-steroidal anti-inflammatory drug (NSAID) on the response to Urografin injection. SF samples were collected under general anaesthesia prior to and at 24 and 72 h after each Urografin injection. The volume, relative viscosity, white blood cell count and concentrations of protein, lactate dehydrogenase (LDH) and hyaluronic acid of these samples were determined. The results from both studies indicate that intra-articular injection of Urografin provoked a mild local transient inflammatory response, the most dramatic evidence of which was an increase in the white blood cell count in the SF after 24 h. In the second study, comparison of the synovial fluid measurements of the placebo-treated dogs at 24 h after Urografin injection with those prior to injection revealed significant increases in SF volume, white blood cell count, protein concentration and LDH activity and a significant reduction in relative viscosity. At 72 h after injection, only the white blood cell count and relative viscosity were significantly different from the pre-injection values.(ABSTRACT TRUNCATED AT 250 WORDS)

Long-term effects of cimaterol in Friesian steers: I. Growth, feed efficiency, and selected carcass traits.

The objectives of this experiment were: 1) to determine whether feeding cimaterol to male calves from 4 wk of age until slaughter at target live weights of 275, 375, or 475 kg would result in a sustained increase in growth rate and feed conversion efficiency (FCE) and 2) to determine whether the effects of cimaterol on selected carcass traits would increase with increased duration of treatment. Ninety male Friesian calves 4 wk old were assigned at random to either a control or cimaterol group. Each animal was fed 1 kg of chopped barley straw and had ad libitum access to a pelleted diet containing either 0 or 4 ppm of cimaterol. Neither ADG nor FCE was affected by cimaterol during the first 5 wk of treatment. Growth rate of cimaterol-treated steers was 20% higher during wk 25 to 33. However, cimaterol had no overall effect on growth rate. Feed conversion efficiency was improved by 15 and 63% during wk 9 to 16 and wk 25 to 33, respectively. Cimaterol-treatment increased dressing percentage by an average of 3%, improved conformation score (2.2 vs 4.0, 3.0 vs 3.9, and 2.9 vs 3.2), and reduced subcutaneous fat score (1.7 vs 1.9, 1.3 vs 3.1, and 2.1 vs 3.4) for treated and control animals at target slaughter live weights of 275, 375, and 475 kg, respectively, but had no effect on carcass weight. On average, cimaterol treatment decreased carcass length by 2.5 cm, hide weight by 2.75 kg, and the weight of kidney and pelvic fat by 3.5 kg.(ABSTRACT TRUNCATED AT 250 WORDS)

Long-term effects of cimaterol in Friesian steers: II. Carcass composition and meat quality.

The objectives of this study were to examine the effects of long-term administration of cimaterol to steers from 4 wk of age until slaughter at target live weights of 275, 375, and 475 kg on 1) carcass composition; 2) distribution and growth of the dissectible lean, fat, and bone; and 3) selected meat quality traits. Ninety calves were allocated to either control or cimaterol (4 ppm) treatment with 15 from each treatment scheduled for slaughter at the above target live weights. Of the 90 calves, 73 carcasses were dissected. Cimaterol increased the proportion of lean in the carcass of the three target slaughter groups from 653, 629, and 612 g/kg in control steers to 728, 728, and 723 g/kg in treated steers, respectively, and decreased the proportion of fat from 134, 169, and 197 g/kg in control steers to 88, 86, and 99 g/kg in treated steers, respectively. Cimaterol increased the longissimus muscle area from 46.4, 56.7, and 62.4 cm2 in control steers to 61.0, 73.4, and 90.8 cm2 in treated steers in the three target slaughter groups, respectively. The allometric growth coefficients for total lean, bone, and fat were .987, .869, and 1.406, respectively, for treated animals and .898, .771, and 1.654, respectively, for control animals. Cimaterol increased the 2-d drip loss and the fiber-optic probe value of longissimus muscle. Shear force values were 55, 145, and 118% higher in the treated animals in the three target slaughter groups, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

The effect of estradiol, trenbolone acetate, or zeranol on growth rate, mammary development, carcass traits, and plasma estradiol concentrations of beef heifers.

The effect of a single implantation (on d 1) with one or two long-acting, biodegradable estradiol implants (1E or 2E) on plasma estradiol concentrations in beef heifers was determined. The growth rates of these (2E) heifers, and of heifers repeatedly implanted with trenbolone acetate (TBA) or zeranol (Z) on d 1, 84, 168, and 252 of the trial, were compared to growth rates of controls. Trenbolone acetate alone was compared to TBA + 2E, and 2E was compared to 1E. At a mean age of 84 d (d 1 of experiment), 81 Hereford x Friesian heifers were allocated at random to the following treatments: Control (n = 15); TBA (n = 15); 1E (n = 12); 2E (n = 15); Z (n = 13); or TBA + 2E (n = 11). Mean live weight (kg) prior to slaughter on d 368 and hot carcass weight (kg) for heifers assigned to treatment Groups 1 to 6, respectively, were 366 and 200, 391 and 212, 374 and 201, 386 and 207, 387 and 210, and 391 and 208 (residual SD = 30.3 and 20.2). Heifers assigned to both the 2E and Z treatments were heavier on d 368 (P less than .05) and had longer teats on d 279 (P less than .05), less pelvic fat (P less than .05), and heavier kidneys (P less than .005) than control heifers. Heifers assigned to the TBA treatment had shorter teats on d 279 (P less than .001) but greater final live weight (P less than .05) and carcass weight than control heifers. Heifers given TBA alone had more pelvic fat (P less than .05) and lighter kidneys (P less than .05) than those given TBA + 2E. Mean estradiol concentrations in both the ipsilateral and contralateral jugular veins of heifers assigned to the 2E and TBA + 2E treatments, and in the ipsilateral jugular veins of heifers given 1E, were greater (P less than .05) than those in control heifers; concentrations did not decline during the experiment.

The effects of buscopan compositum on calf nutritional diarrhoea.

Nutritional diarrhoea was induced in male Friesian calves by the addition of sucrose to their milk replacer diet in two experiments. In each study the calves were paired on the basis of the severity of the diarrhoea and each of a pair of calves was assigned at random to receive a course of six intramuscular injections (5 ml/50 kg body weight) of either a placebo or Buscopan compositum (morning and evening) over a period of 3 days. In an initial study, which involved 10 pairs of calves, daily faecal and urine output were collected separately for each calf on the day prior to the start of treatment and on each day of the 3 treatment days. The daily output of fresh faeces were reduced as a result of treatment with Buscopan compositum and the overall reduction for the complete 3 day period was 18.7%. This was also reflected in a reduced output of faecal water (18.4%) during the same period. The digestibility of the dry matter component of the diet was significantly increased by 5.8%. In a second experiment, which involved 24 pairs of calves, faecal samples were collected daily, commencing before initiation of treatment, for determination of faecal dry matter content. The pattern of change in the faecal dry matter content during the course of the study differed clearly for the two treatments. Faecal dry matter increased from its lowest level (11.7%), immediately prior to first treatment, to its maximum (21.8%) on the second day of treatment in the Buscopan compositum-treated calves.(ABSTRACT TRUNCATED AT 250 WORDS)

Cimaterol reduces cathepsin activities but has no anabolic effect in cultured myotubes.

The effect of the beta-adrenergic agonist cimaterol on bovine and chicken primary myotubes was assessed. Cimaterol at 10-100 nM concentrations reduced cathepsin B benzyloxy-carbonyl-Arg-Arg-4-methyl-7-coumarylamide hydrolyzing activity, as well as benzyloxycarbonyl-Phe-Arg-4-methyl-7-coumarylamide hydrolysis, which is a substrate for both cathepsin B and cathepsin L. Maximum effect was observed after 6-16 h treatment. Cathepsin H Arg-4-methyl-7-coumarylamide hydrolyzing activity was low and not significantly affected by cimaterol treatment. Despite decreasing cathepsin activities, cimaterol also increased proteolysis rates but induced no detectable effect on protein synthesis rates. These observations suggest that beta-agonists, as a result of a direct action on muscle, can decrease cathepsin activities but that beta-agonist-induced muscle hypertrophy may not be due to a direct effect on muscle cells.

Effect of immunization of ewes against prostaglandin F-2 alpha on the life-span of corpora lutea and oestrous behaviour during two breeding seasons.

Two adjuvants, Freund's complete adjuvant (FCA) and GNE (proprietary product; Intervet Ltd, The Netherlands), were used to immunize cyclic Finnish Landrace ewes (4-6/treatment) against a prostaglandin F-2 alpha-human serum albumin (PGF-HSA) conjugate. Ewes were randomized to the following treatments: (a) control-untreated, (b) control-5 mg HSA in FCA (control-HSA), (c) 5 mg PGF-HSA in FCA (FCA-5 mg), (d) 15 mg PGF-HSA in FCA (FCA-15 mg), (e) 5 mg PGF-HSA in GNE (GNE-5 mg) and (f) 15 mg PGF-HSA in GNE (GNE-15 mg). Ewes were monitored for oestrus (twice daily) and ovarian activity (progesterone concentrations in blood samples taken twice weekly) for 2 consecutive breeding seasons. In the first breeding season, the mean number of oestrous periods detected was 6.0, 5.7, 0.0, 0.2, 1.8 and 0.5 in control, control-HSA, FCA-5 mg, FCA-15 mg, GNE-5 mg and GNE-15 mg-assigned ewes, respectively [pooled standard error of difference (s.e.d.) = 1.2]. A persistent CL formed, on average, 10.0, 10.0, 29.8 and 32.5 days after primary immunization (pooled s.e.d. = 14.6) in 6/6 FCA-5 mg, 6/6 FCA-15 mg, 5/6 GNE-5 mg and 4/4 GNE-15 mg-assigned ewes, respectively; these CL were maintained for, on average, 138.7, 139.0, 127.8 and 129.0 days, respectively (pooled s.e.d. = 15.9).(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of long-term administration of pituitary-derived bovine growth hormone and estradiol on growth in steers.

Sixty-three Friesian steers (9 mo old, 257 kg; n = 15 or 16/treatment) were employed in a 2 x 2 factorial to test bovine growth hormone (bGH) and estradiol (Compudose implant). Steers received daily subcutaneous injections of vehicle or bGH (40 micrograms/kg body weight) for 22 wk. Steers were slaughtered 8 wk after the end of bGH treatment (wk 30). Steers had ad libitum access to silage plus a fixed amount (4 to 5.5 kg/d) of concentrate. Average daily gain (ADG) and feed conversion efficiency (FCE) improved (P less than .05) in response both to bGH and to estradiol during wk 0 to 22. Although bGH did not affect ADG or FCE during wk 23 to 30, estradiol improved (P less than .05) them; bGH and estradiol appeared additive (nonsignificant interactions) during wk 0 to 22. At slaughter, estradiol increased (P less than .05) carcass weight and carcass and leg length while decreasing (P less than .05) conformation score and percentage of kidney, knob and channel fat (KHP); bGH decreased (P less than .05) KHP. Although both bGH and estradiol increased (P less than .01) plasma GH, their effects were not additive. Both bGH and estradiol increased (P less than .01) plasma somatomedin-C and decreased (P less than .01) plasma urea nitrogen concentrations; effects were additive. Estradiol, but not bGH, increased (P less than .05) plasma glucose, whereas neither bGH nor estradiol altered plasma creatinine and nonesterified fatty acids. In summary, both bGH and estradiol improved growth and FCE, and their effects appeared to be additive. It is likely that some of their effects were mediated by somatomedin-C.

Effects of oestradiol, zeranol or trenbolone acetate implants on puberty, reproduction and fertility in heifers.

The effects of anabolic agents on reproduction in beef heifers were determined by using 300 mg trenbolone acetate (TBA), 36 mg zeranol and 19 mg oestradiol-17 beta in a biodegradable pellet (1E: American Cyanamid, USA), or two such pellets (2E). On Day 1 of experiment, 81 Hereford x Friesian heifers (mean age = 84 +/- 1.2 days) were allocated at random to the following treatments: (1) controls (N = 15); (2) TBA (N = 15); (3) 1E (N = 12); (4) 2E (N = 15); (5) zeranol (N = 13); (6) TBA + 2E (N = 11). The 1 (1E), or 2 (2E) oestradiol implants were administered on Day 1 of the experiment only. Heifers assigned to receive TBA and zeranol were implanted on Days 1, 84, 168 and 252. Blood progesterone concentrations and oestrous activity were monitored from Days 137 and 200 respectively. Mean age (days) and weight (kg) at puberty (first ovulation), for heifers that reached puberty in Groups 1-6 respectively were 352 and 308, 419 and 356, 373 and 325, 381 and 331, 400 and 353, 423 and 383 [residual standard deviation (r.s.d.) = 43.8 and 39.4 for age and weight respectively]. Heifers in Group 4 were older (P less than 0.05), but not heavier (P greater than 0.05), while those in Groups 2 and 5 were both older (P less than 0.005) and heavier (P less than 0.005) than the controls at puberty. Age and weight at puberty were not different in heifers assigned to Groups 3 and 4, or to Groups 2 and 6. The proportion of heifers showing oestrus before puberty (prepubertal oestrus) were 3/15, 12/15, 6/12, 7/15, 10/13 and 11/11 in Groups 1-6 respectively. Heifers in Groups 2 and 5 had higher incidences of prepubertal oestrus than controls, while those in other treatment groups were not different. There was no treatment effect on the incidence of silent ovulations, but the incidence of non-ovulatory oestrus, after puberty, was increased from 4/48 in Group 1 to 26/40 (P less than 0.001), 15/56 (P less than 0.05) and 34/57 (P less than 0.001) in Groups 2, 4 and 5, respectively. Heifers in Group 6 had a higher incidence of non-ovulatory oestrus (P less than 0.05), but not of prepubertal oestrus, than did those in Group 2.(ABSTRACT TRUNCATED AT 400 WORDS)

Ovarian follicular dynamics in lines of sheep (Finn, Merinos) selected on ovulation rate.

Ewes from selected lines of sheep from each of two breeds, Finns (high ovulation rate, low ovulation rate and control lines with respective ovulation rates of 5.4, 2.7 and 3.3) and Merinos (T Merinos selected for increased ovulation rate and control Merinos with respective ovulation rates of 1.9 and 1.2) were used to examine how selection to alter ovulation rate had altered follicle development. Ovarian antral follicles were counted, measured, classified as nonatretic or atretic (more than five pyknotic bodies). The growth of ovulatory follicles in vivo, followed by repeated follicle ink marking, also was compared in the three lines of Finns. Regardless of breed, ewes selected for high ovulation rate had a similar number of antral follicles and a similar extent of atresia compared with their controls. Alterations induced by selection were located in the last stages of folliculogenesis. T Merinos exhibited a lower proportion of atretic follicles among follicles greater than 3 mm and a larger diameter of the largest healthy follicle when preovulatory follicles were excluded. High-line Finn ewes recruited more follicles, which produced smaller preovulatory follicles, each containing a smaller number of granulosa cells compared with either the low- or control-line ewes. Hence, physiological selection for high ovulation rate raised it by different methods in Merino than in Finn ewes.

Release of prostaglandin F-2 alpha and the timing of events associated with luteolysis in ewes with oestrous cycles of different lengths.

Ewes (N = 32) were bled every 2 h from 5 days before expected oestrus until the end of oestrus. Plasma concentrations were determined for progesterone to monitor luteal activity and for the prostaglandin F-2 alpha (PGF-2 alpha) metabolites, 15-keto-13,14-dihydro-PGF-2 alpha and 11-ketotetranor-PGF to determine uterine synthesis and release of PGF-2 alpha. Most of the variation in cycle length was associated with the time of onset of luteolysis, the timing of events after luteolysis being constant and not related to cycle length. The time of occurrence of the first PGF-2 alpha pulse and the interval between this pulse and the start of luteolysis were the two main determinants responsible for oestrous cycle length. Several PGF-2 alpha pulses with interpulse intervals of 15.9 h occurred before the onset of functional luteolysis compared with 7.7 h for pulses associated with luteolysis. The numbers of PGF-2 alpha pulses and interpulse intervals were similar for oestrous cycles of different lengths. While a gradual decline in progesterone concentrations was observed before functional luteolysis in the ewes with longer cycles, this did not appear to be an integral part of the stimulus which initiates the pulse frequency of PGF-2 alpha required for luteolysis. We therefore suggest that differences in oestrous cycle length in the ewe are determined by the time of the onset of PGF-2 alpha pulsatile release, and especially by the time of increased pulse frequency.

Gonadotrophin secretion during the periovulatory period in Galway and Finnish Landrace ewes and Finnish Landrace ewes selected for high ovulation rate.

Rates of ovulation differed significantly (P less than 0.01) among ewes of the different genetic lines. However, of the reproductive characteristics studied, only progesterone concentration at the height of luteal function, duration of oestrus, and interval from onset of oestrus to peak of the preovulatory gonadotrophin surge showed significant positive association with rate of ovulation. The pattern of secretion of LH during the periovulatory period did not differ in the Galway and Finnish Landrace breeds. The total amount of LH secreted during the preovulatory surge did not differ amongst lines. Similarly, no difference in the plasma concentration of LH at the height of the preovulatory surge was noted among Galway and reference Finnish Landrace lines. However, the concentration of LH at the height of the surge was significantly (P less than 0.05) reduced in the selected Finnish Landrace line. Plasma concentrations of FSH during the preovulatory period were significantly (P less than 0.05) elevated in the breed (Galway) with the lowest prolifcacy. When contrasted with either of the Finnish Landrace lines, the magnitudes of the preovulatory surge of FSH and the secondary surge of FSH were significantly greater (P less than 0.05) in Galway ewes. These results suggest that genetic difference in rate of ovulation among sheep breeds is not tightly coupled to quantitative differences in plasma concentration of gonadotrophic hormones during the periovulatory period.

Natural and induced ovulation rate in prolific and non-prolific breeds of sheep in Ireland, Morocco and New Zealand.

Ovulation rate, in mixed-age groups of prolific and non-prolific ewe breed types, after administration of a range of doses of PMSG (0, 375, 750 and 1500 i.u.) during the follicular phase of the oestrous cycle, were compared in Ireland, Morocco and New Zealand. The ewes in Ireland and Morocco were from the Finnish Landrace and Galway, and D'Man and Timhadite breeds, respectively. In New Zealand Booroola Merino x Romney ewes which had been previously identified as heterozygous carriers (F+) of the Booroola high fecundity gene and purebred Romneys were used to represent the prolific and non-prolific genotypes respectively; in addition a group of Booroola Merino x Romney non-carriers (++) of the major gene were also included for comparison. Ovulation rate at the oestrus which preceded stimulation with PMSG was also measured in all animals. In all 3 locations the ewes of the prolific genotype had a greater ovulation rate after PMSG stimulation than did the non-prolific controls. However, this association between prolificacy and response to PMSG was removed when ovulation rate after PMSG was transformed by dividing by the ovulation rate observed before PMSG administration. Despite the differences in the genetic basis of their high prolificacy the pattern of response to PMSG over the range of dosages used was similar in Finnish Landrace, D'Man and Booroola Merino x Romney (F+) ewes and all breeds had means of about 10 ovulations in response to 1500 i.u. PMSG. Amongst the non-prolific breeds, the Timhadite was the most responsive to PMSG although it had the lowest natural ovulation rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of long acting and short acting oestradiol implants on growth rate and carcase weight of steers.

The effects of a number of steroid hormone treatments on growth were examined in a trial involving 204 Friesian-type steers which was carried out over an 11 month period from May to April. The animals were at pasture from May until October and were over-wintered indoors on grass silage and supplementary concentrates. Thirty-four animals were used as untreated controls, and there were four treatment groups: 43 steers were implanted with pellet-type implants containing 20 mg oestradiol benzoate and 200 mg progesterone on days 1, 105 and 187; 47 steers were implanted with a single silastic rubber implant containing 45 mg oestradiol-17 beta; 36 steers received treatment (1) and in addition were implanted on the same days with 300 mg trenbolone acetate; 44 steers received treatment (2) and were also implanted with 300 mg trenbolone acetate on days 1, 105 and 187. The mean liveweight gains (+/- sem) of the steers during the first 249 days of the trial were 201.7 kg for the controls and 236.8, 219.4, 254.4 and 247.8 (+/- 6.1) kg for the steers assigned to treatments 1, 2, 3 and 4, respectively. The corresponding values for the carcase weights (+/- sem) were 300.0 kg for the controls and 318.4, 312.0, 327.9 and 321.6 (+/- 3.5) kg for the treated groups. Although all the treatments increased the liveweight gains and carcase weights significantly compared with the controls, the responses to the silastic rubber implants were smaller owing primarily to an apparently high rate of loss of the implants.(ABSTRACT TRUNCATED AT 250 WORDS)

Reproduction in Javanese sheep: evidence for a gene with large effect on ovulation rate and litter size.

Three breeds of Javanese sheep are described briefly and data suggesting the segregation of a gene with large effect on ovulation rate and litter size are presented. The three breeds are Javanese Thin Tail (JTT), Javanese Fat Tail (JFT) and Semarang (SEM), the last possibly a substrain of JTT. All three breeds have mean mature ewe weights under 30 kg. Ovulation rate and litter size did not differ significantly among the three; all had litter sizes of up to 4 or 5 with a mean for mature ewes of approximately 2. Ovulation rate ranged from 1 to 5 and had an average within-breed repeatability of .8 within season and .65 between seasons. Within-breed repeatability of litter size was .35 +/- .06. Prenatal survival in pregnant ewes with two, three and four or more ovulations averaged 93, 88 and 86% over two seasons. Dams that had at least one ovulation rate or litter size record greater than or equal to 3 produced two groups of daughters in approximately equal numbers: one group with many records greater than or equal to 3 and mean ovulation rate and litter size of 2.73 and 2.31, respectively, and one group with ovulation rates and litter sizes of 1 or 2 and corresponding means of 1.39 and 1.38. Dams with ovulation rate or litter size records of only 1 or 2 produced daughters in which over 90% had records of only 1 or 2. Estimated heritabilities for the mean of approximately three ovulation rate or litter size records from these daughter-dam comparisons exceeded .7. These results suggest segregation of a Booroola-type gene, one copy of which increases ovulation rate by about 1.3 and litter size by .9 to 1.0. Relationships between duration of estrus and ovulation rate, and between timing of release of luteinizing hormone and number of eggs shed, resemble the pattern in Booroola Merino more closely than that in Finnish Landrace or Romanov, supporting the hypothesis of a major gene.